Cargando…

ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195

BACKGROUND: Several members of the zinc finger protein family have been recently shown to have a role in cancer initiation and progression. Zinc finger protein 367 (ZNF367) is a member of the zinc finger protein family and is expressed in embryonic or fetal erythroid tissue but is absent in normal a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Meenu, Zhang, Lisa, Boufraqech, Myriem, Liu-Chittenden, Yi, Bussey, Kimberly, Demeure, Michael J., Wu, Xiaolin, Su, Ling, Pacak, Karel, Stratakis, Constantine A., Kebebew, Electron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105551/
https://www.ncbi.nlm.nih.gov/pubmed/25047265
http://dx.doi.org/10.1371/journal.pone.0101423
Descripción
Sumario:BACKGROUND: Several members of the zinc finger protein family have been recently shown to have a role in cancer initiation and progression. Zinc finger protein 367 (ZNF367) is a member of the zinc finger protein family and is expressed in embryonic or fetal erythroid tissue but is absent in normal adult tissue. METHODOLOGY/PRINCIPAL FINDINGS: We show that ZNF367 is overexpressed in adrenocortical carcinoma, malignant pheochromocytoma/paraganglioma and thyroid cancer as compared to normal tissue and benign tumors. Using both functional knockdown and ectopic overexpression in multiple cell lines, we show that ZNF367 inhibits cellular proliferation, invasion, migration, and adhesion to extracellular proteins in vitro and in vivo. Integrated gene and microRNA expression analyses showed an inverse correlation between ZNF367 and miR-195 expression. Luciferase assays demonstrated that miR-195 directly regulates ZNF367 expression and that miR-195 regulates cellular invasion. Moreover, integrin alpha 3 (ITGA3) expression was regulated by ZNF367. CONCLUSIONS/SIGNIFICANCE: Our findings taken together suggest that ZNF367 regulates cancer progression.